US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lexicon Pharmaceuticals

0.5098

+0.00981.96%

Post-market: 0.51000.0002+0.04%19:59 EDT

Volume:2.67M

Turnover:1.36M

Market Cap:184.29M

PE:-0.81

High:0.5262

Open:0.5001

Low:0.4980

Close:0.5000

Loading ...

Overview Company News Filings

Lexicon Pharmaceuticals Inc (LXRX) Q4 2024 Earnings Call Highlights: Strategic Advances and ...

Lexicon Pharmaceuticals Advances Pipeline Amid Financial Growth

Lexicon Pharmaceuticals (LXRX) Reports Q4 Loss, Tops Revenue Estimates

Lexicon Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Lexicon: Q4 Earnings Snapshot

Associated Press Finance

Lexicon Pharmaceuticals Q4 EPS $(0.09) Beats $(0.12) Estimate, Sales $26.55M Beat $6.48M Estimate

Lexicon Pharmaceuticals Q4 Operating Expenses USD 59.291 Million

THOMSON REUTERS

Lexicon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Leerink Partners Downgrades Lexicon Pharmaceuticals to Market Perform From Outperform, Adjusts PT to $1 From $2

MT Newswires Live

Lexicon Pharma Cut to Market Perform From Outperform by Leerink Partners

Lexicon downgraded to Market Perform from Outperform at Leerink

Lexicon Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

Lexicon Pharma Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

H.C. Wainwright Remains a Buy on Lexicon Pharmaceuticals (LXRX)

Lexicon Pharmaceuticals’ Promising Phase 2b Trial Results for Pilavapadin Drive Buy Rating

Lexicon Pharmaceuticals (LXRX) Gets a Hold from Needham

Lexicon Says Pilavapadin Showed 'Meaningful' Pain Reduction But Results Miss Primary Endpoint

MT Newswires Live

Lexicon Pharmaceuticals to Announce Topline Results from Phase 2b PROGRESS Study Evaluating Pilavapadin (LX9211) in Adults with Diabetic Peripheral Neuropathic Pain

Lexicon’s sotagliflozin shows cardiovascular efficacy in published study

ANALYSIS-Europe's AI bulls pin hopes on 'Jevons Paradox' after DeepSeek rout

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LXRX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LXRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LXRX\",,,,,undefined,":{"symbol":"LXRX","market":"US","secType":"STK","nameCN":"Lexicon Pharmaceuticals","latestPrice":0.5098,"timestamp":1744920000000,"preClose":0.5,"halted":0,"volume":2671184,"hourTrading":{"tag":"盘后","latestPrice":0.51,"preClose":0.5098,"latestTime":"19:59 EDT","volume":33879,"amount":17182.24921,"timestamp":1744934386810},"delay":0,"floatShares":182278260,"shares":361492295,"eps":-0.626198,"marketStatus":"Market Closed","change":0.0098,"latestTime":"04-17 16:00:00 EDT","open":0.5001,"high":0.5262,"low":0.498,"amount":1358202.236968,"amplitude":0.0564,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.626198,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":955080000000,"exchange":"NASDAQ","adjPreClose":0.5,"preHourTrading":{"tag":"盘前","latestPrice":0.5049,"preClose":0.5,"latestTime":"09:21 EDT","volume":19430,"amount":9839.8972058,"timestamp":1744896100607},"postHourTrading":{"tag":"盘后","latestPrice":0.51,"preClose":0.5098,"latestTime":"19:59 EDT","volume":33879,"amount":17182.24921,"timestamp":1744934386810},"volumeRatio":0.47048795876422367,"impliedVol":1.8017,"impliedVolPercentile":0.7649},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LXRX\",,,,,undefined,":{"symbol":"LXRX","floatShares":182278260,"roa":"-43.77%","roe":"-167.66%","lyrEps":-0.626198,"volumeRatio":0.47048795876422367,"shares":361492295,"dividePrice":0,"high":0.5262,"amplitude":0.0564,"preClose":0.5,"low":0.498,"week52Low":0.2836,"pbRate":"1.26","psRate":"5.93","week52High":2.45,"institutionHeld":0.7684,"latestPrice":0.5098,"eps":-0.626198,"divideRate":0,"volume":2671184,"delay":0,"ttmEps":-0.626198,"open":0.5001,"prevYearClose":0.7385,"prevWeekClose":0.5118,"prevMonthClose":0.4608,"prevQuarterClose":0.4608,"fiveDayClose":0.4953,"twentyDayClose":0.3449,"sixtyDayClose":0.84},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LXRX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517907176","title":"Lexicon Pharmaceuticals Inc (LXRX) Q4 2024 Earnings Call Highlights: Strategic Advances and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2517907176","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517907176?lang=en_us&edition=fundamental","pubTime":"2025-03-07 15:17","pubTimestamp":1741331840,"startTime":"0","endTime":"0","summary":"Cash Equivalents and Short-term Investments: $238 million as of December 31, 2024, compared to $170 million as of December 30, 2023.Revenue: $26.6 million in Q4 2024 and $31.1 million for the full year 2024.MEA Revenue: $1.7 million in Q4 2024 and $6 million for the full year 2024.Upfront Payment: $25 million received from the Vatrice licensing agreement.Research and Development Expenses: $26.7 million in Q4 2024, up from $14.8 million in Q4 2023; $84.5 million for the full year 2024.Selling, General and Administrative Expenses: $32.3 million in Q4 2024, comparable to $32.6 million in Q4 2023; $143.1 million for the full year 2024, up from $114 million in 2023.Net Loss: $33.8 million or $0.09 per share in Q4 2024, compared to $49.8 million or $0.20 per share in Q4 2023; $200.4 million or $0.32 per share for the full year 2024, compared to $177.1 million or $0.80 per share in 2023.Lexicon Pharmaceuticals Inc  ceased all promotional efforts for MEPA in the US due to a challenging market ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lexicon-pharmaceuticals-inc-lxrx-q4-071720592.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LXRX"],"gpt_icon":0},{"id":"2517126981","title":"Lexicon Pharmaceuticals Advances Pipeline Amid Financial Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2517126981","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517126981?lang=en_us&edition=fundamental","pubTime":"2025-03-07 12:26","pubTimestamp":1741321560,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals ( ($LXRX) ) has released its Q4 earnings. Here is a breakdown of the information Lexicon Pharmaceuticals presented to its i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lexicon-pharmaceuticals-advances-pipeline-amid-financial-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lexicon-pharmaceuticals-advances-pipeline-amid-financial-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"2517142110","title":"Lexicon Pharmaceuticals (LXRX) Reports Q4 Loss, Tops Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2517142110","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517142110?lang=en_us&edition=fundamental","pubTime":"2025-03-07 06:10","pubTimestamp":1741299003,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals  came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.20 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 18.18%. A quarter ago, it was expected that this drugmaker would post a loss of $0.17 per share when it actually produced a loss of $0.18, delivering a surprise of -5.88%.Over the last four quarters, the company has surpassed consensus EPS estimates two times.Lexicon , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $26.55 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 215.37%. This compares to year-ago revenues of $0.7 million. The company has topped consensus revenue estimates just once over the last four quarters.Investors should be mindful of the fact that the outlook for the industry can have a material impact on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lexicon-pharmaceuticals-lxrx-reports-q4-221003063.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LXRX"],"gpt_icon":0},{"id":"2517116418","title":"Lexicon Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2517116418","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517116418?lang=en_us&edition=fundamental","pubTime":"2025-03-07 06:01","pubTimestamp":1741298474,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings SummaryLexicon Pharmaceuticals Inc LXRX.OQ reported a quarterly adjusted loss of 9 cents per share for the quar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL5N3PP2HS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX"],"gpt_icon":0},{"id":"2517113438","title":"Lexicon: Q4 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2517113438","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517113438?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:18","pubTimestamp":1741295911,"startTime":"0","endTime":"0","summary":"THE WOODLANDS, Texas  — THE WOODLANDS, Texas  — Lexicon Pharmaceuticals Inc.  on Thursday reported a loss of $33.8 million in its fourth quarter.On a per-share basis, the The Woodlands, Texas-based company said it had a loss of 9 cents.The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 11 cents per share.The drugmaker posted revenue of $26.6 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $8.4 million.For the year, the company reported a loss of $200.4 million, or 63 cents per share. Revenue was reported as $31.1 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lexicon-q4-earnings-snapshot-211831228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LXRX"],"gpt_icon":0},{"id":"2517118125","title":"Lexicon Pharmaceuticals Q4 EPS $(0.09) Beats $(0.12) Estimate, Sales $26.55M Beat $6.48M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2517118125","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517118125?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:02","pubTimestamp":1741294931,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.12) by 25 percent. This is a 55 percent increase over losses of $(0.20) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44179156/lexicon-pharmaceuticals-q4-eps-0-09-beats-0-12-estimate-sales-26-55m-beat-6-48m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Lexicon Pharmaceuticals Q4 EPS $(0.09) Beats $(0.12) Estimate, Sales $26.55M Beat $6.48M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX"],"gpt_icon":1},{"id":"2517118831","title":"Lexicon Pharmaceuticals Q4 Operating Expenses USD 59.291 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517118831","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517118831?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:00","pubTimestamp":1741294800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nPLX322592:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"2517433113","title":"Lexicon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2517433113","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517433113?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:00","pubTimestamp":1741294800,"startTime":"0","endTime":"0","summary":"Topline Results for Phase 2b PROGRESS Study of Pilavapadin  in Diabetic Peripheral Neuropathic Pain ; 10 mg dose to Advance into Phase 3 Development. THE WOODLANDS, Texas, March 06, 2025  -- Lexicon Pharmaceuticals, Inc. , today reported financial results for the three months and year ended December 31, 2024, and provided an update on key corporate milestones and accomplishments.“In 2024, Lexicon made progress on our Lead to Succeed strategy, resulting in a complete repositioning of the company to focus on advancing our R&D pipeline,” said Mike Exton, Ph.D., Lexicon’s chief executive officer and director. “With R&D efforts our core priority, we were pleased to report progress on three programs. First, we recently reported topline results from the PROGRESS Phase 2b study of pilavapadin, our novel non-opioid, oral, investigational therapy for neuropathic pain with potential to be the first new therapy for neuropathic pain in over two decades. We met our study objectives with respect to t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lexicon-pharmaceuticals-reports-fourth-quarter-210000894.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","LXRX","BK4139","BK4531","BK4007","BK4585","HCM"],"gpt_icon":0},{"id":"2517911266","title":"Leerink Partners Downgrades Lexicon Pharmaceuticals to Market Perform From Outperform, Adjusts PT to $1 From $2","url":"https://stock-news.laohu8.com/highlight/detail?id=2517911266","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517911266?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:21","pubTimestamp":1741180902,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals (LXRX) has an average rating of overweight and mean price target of $3.40, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PT","LXRX"],"gpt_icon":0},{"id":"2517980969","title":"Lexicon Pharma Cut to Market Perform From Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2517980969","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517980969?lang=en_us&edition=fundamental","pubTime":"2025-03-05 07:06","pubTimestamp":1741129560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LXRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 04, 2025 18:06 ET (23:06 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX"],"gpt_icon":0},{"id":"2517022989","title":"Lexicon downgraded to Market Perform from Outperform at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2517022989","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517022989?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:17","pubTimestamp":1741123030,"startTime":"0","endTime":"0","summary":"Leerink analyst Roanna Ruiz downgraded Lexicon (LXRX) to Market Perform from Outperform with a price target of $1, down from $2. The “modest” effic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexicon-downgraded-to-market-perform-from-outperform-at-leerink?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexicon-downgraded-to-market-perform-from-outperform-at-leerink?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"2517230989","title":"Lexicon Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2517230989","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517230989?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:15","pubTimestamp":1741122900,"startTime":"0","endTime":"0","summary":"THE WOODLANDS, Texas, March 04, 2025  -- Lexicon Pharmaceuticals, Inc.  today announced the Company will release its fourth quarter and full year 2024 financial results on Thursday, March 6, 2025 after the markets close. Management will conduct a conference call and live webcast at 5:00 p.m. ET  that day to discuss the financial results and to provide a business update.For Investor and Media Inquiries:Lisa DeFrancescoLexicon Pharmaceuticals, Inc.lexinvest@lexpharma.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lexicon-pharmaceuticals-report-fourth-quarter-211500182.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"2516651562","title":"Lexicon Pharma Price Target Maintained With a $4.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2516651562","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516651562?lang=en_us&edition=fundamental","pubTime":"2025-03-04 01:49","pubTimestamp":1741024140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LXRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 03, 2025 12:49 ET (17:49 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX"],"gpt_icon":0},{"id":"2516659806","title":"H.C. Wainwright Remains a Buy on Lexicon Pharmaceuticals (LXRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516659806","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516659806?lang=en_us&edition=fundamental","pubTime":"2025-03-04 01:05","pubTimestamp":1741021527,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Lexicon Pharmaceuticals (LXRX – Research Report) today and set a price target o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-lexicon-pharmaceuticals-lxrx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-lexicon-pharmaceuticals-lxrx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"2516765980","title":"Lexicon Pharmaceuticals’ Promising Phase 2b Trial Results for Pilavapadin Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2516765980","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516765980?lang=en_us&edition=fundamental","pubTime":"2025-03-04 01:05","pubTimestamp":1741021521,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals (LXRX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joseph Pantg...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/lexicon-pharmaceuticals-promising-phase-2b-trial-results-for-pilavapadin-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/lexicon-pharmaceuticals-promising-phase-2b-trial-results-for-pilavapadin-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LXRX"],"gpt_icon":0},{"id":"2516265650","title":"Lexicon Pharmaceuticals (LXRX) Gets a Hold from Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2516265650","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516265650?lang=en_us&edition=fundamental","pubTime":"2025-03-04 00:45","pubTimestamp":1741020327,"startTime":"0","endTime":"0","summary":"Needham analyst Joseph Stringer maintained a Hold rating on Lexicon Pharmaceuticals (LXRX – Research Report) today. The company’s shares opened tod...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lexicon-pharmaceuticals-lxrx-gets-a-hold-from-needham-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lexicon-pharmaceuticals-lxrx-gets-a-hold-from-needham-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LXRX","BK4139"],"gpt_icon":0},{"id":"2516636621","title":"Lexicon Says Pilavapadin Showed 'Meaningful' Pain Reduction But Results Miss Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2516636621","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516636621?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:40","pubTimestamp":1741009244,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals  said Monday a phase 2b study evaluating pilavapadin for diabetic peripheral neuropathic pain demonstrated that the  oral, non-opioid achieved \"meaningful\" pain reduction versus placebo and was well-tolerated in the 10 mg dose.The company said, however, that the study results \"did not reach statistical significance on the primary endpoint.\"Adverse events were more frequent in the pilavapadin treatment arms, but nearly all were reported as mild or moderate, the company said.Lexicon indicated plans to move forward with the 10 mg dose into phase 3 development, targeting the considerable unmet need for non-opioid options in diabetic peripheral neuropathic pain.Lexicon shares were down by nearly 50% in recent premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LXRX"],"gpt_icon":1},{"id":"2516424585","title":"Lexicon Pharmaceuticals to Announce Topline Results from Phase 2b PROGRESS Study Evaluating Pilavapadin (LX9211) in Adults with Diabetic Peripheral Neuropathic Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2516424585","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516424585?lang=en_us&edition=fundamental","pubTime":"2025-03-03 05:13","pubTimestamp":1740949980,"startTime":"0","endTime":"0","summary":"Conference call and webcast at 8:00 a.m. ET on Monday, March 3, 2025THE WOODLANDS, Texas, March  02, 2025  (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/02/3035198/0/en/Lexicon-Pharmaceuticals-to-Announce-Topline-Results-from-Phase-2b-PROGRESS-Study-Evaluating-Pilavapadin-LX9211-in-Adults-with-Diabetic-Peripheral-Neuropathic-Pain.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2065732104.USD","LXRX","PRGS","BK4097"],"gpt_icon":1},{"id":"2512157974","title":"Lexicon’s sotagliflozin shows cardiovascular efficacy in published study","url":"https://stock-news.laohu8.com/highlight/detail?id=2512157974","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512157974?lang=en_us&edition=fundamental","pubTime":"2025-02-18 21:16","pubTimestamp":1739884588,"startTime":"0","endTime":"0","summary":"Lexicon (LXRX) announced The Lancet Diabetes & Endocrinology has published a research paper analyzing the ability of sotagliflozin, a dual SGLT1 an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexicons-sotagliflozin-shows-cardiovascular-efficacy-in-published-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexicons-sotagliflozin-shows-cardiovascular-efficacy-in-published-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LXRX","BK4139"],"gpt_icon":0},{"id":"2508848801","title":"ANALYSIS-Europe's AI bulls pin hopes on 'Jevons Paradox' after DeepSeek rout","url":"https://stock-news.laohu8.com/highlight/detail?id=2508848801","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508848801?lang=en_us&edition=fundamental","pubTime":"2025-02-04 13:30","pubTimestamp":1738647000,"startTime":"0","endTime":"0","summary":"ANALYSIS-Europe's AI bulls pin hopes on 'Jevons Paradox' after DeepSeek routDeepSeek AI selloff sparks debate in Europe'Jevons Paradox' suggests demand could increase as prices fall Tech stocks rebound, but energy needs for AI revolution in focusBy Lucy Raitano. \" The selloff hit direct and indirect AI plays alike. Dutch semiconductor equipment maker ASML ASML.AS, and sector peers ASMI ASMI.AS and BE Semi BESI.AS all fell 7%-12% on Jan. 27, before recouping losses later in the week, as did Siemens Energy ENR1n.DE, which provides hardware for AI infrastructure.\"Jevons Paradox strikes again!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250204:nL3N3OQ10D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDA","LXRX","REL.UK","MSFT","BX","EXPN.UK"],"gpt_icon":1}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":146,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LXRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-06","symbol":"LXRX","fiscalQuarterEnding":"2024/12","expectedEps":-0.11,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":-0.09},{"market":"US","date":"2024-11-12","symbol":"LXRX","fiscalQuarterEnding":"2024/09","expectedEps":-0.17,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2024-08-01","symbol":"LXRX","fiscalQuarterEnding":"2024/06","expectedEps":-0.18,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"post","actualEps":-0.17},{"market":"US","date":"2024-05-02","symbol":"LXRX","fiscalQuarterEnding":"2024/03","expectedEps":-0.18,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1714622400000,"reportTimeType":"post","actualEps":-0.2},{"market":"US","date":"2024-03-11","symbol":"LXRX","fiscalQuarterEnding":"2023/12","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1710129600000,"reportTimeType":"pre","actualEps":-0.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LXRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LXRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.4,"hold":0.4,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":5,"updateTime":1741147200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LXRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LXRX","date":"2025-04-17","current":-0.901913,"percent":0.814483,"low":-63.919063,"twenty":-5.525747,"median":-3.325414,"eighty":-1.172148,"high":23.369026,"avg":-4.476844,"sd":11.617801,"marketCap":180746147},"quantilePoints":[{"date":"2020-04-24","current":1.677706,"twenty":-16.956276,"median":-9.285668,"eighty":-5.581141,"marketCap":218324944},{"date":"2020-05-01","current":2.382153,"twenty":-16.956276,"median":-9.285668,"eighty":-5.481624,"marketCap":203242948},{"date":"2020-05-08","current":2.419766,"twenty":-16.956276,"median":-9.285668,"eighty":-5.386414,"marketCap":206452047},{"date":"2020-05-15","current":2.357078,"twenty":-16.956276,"median":-9.285668,"eighty":-5.317861,"marketCap":201103549},{"date":"2020-05-22","current":2.520068,"twenty":-16.956276,"median":-9.285668,"eighty":-5.213626,"marketCap":215009645},{"date":"2020-05-29","current":2.394691,"twenty":-16.956276,"median":-9.285668,"eighty":-5.107837,"marketCap":204312648},{"date":"2020-06-05","current":2.444842,"twenty":-16.956276,"median":-9.285668,"eighty":-4.989706,"marketCap":208591447},{"date":"2020-06-12","current":2.34454,"twenty":-16.956276,"median":-9.285668,"eighty":-4.825395,"marketCap":200033849},{"date":"2020-06-19","current":2.444842,"twenty":-16.956276,"median":-9.285668,"eighty":-4.715687,"marketCap":208591447},{"date":"2020-06-26","current":2.545143,"twenty":-16.956276,"median":-9.285668,"eighty":-4.628975,"marketCap":217149045},{"date":"2020-07-02","current":2.432304,"twenty":-16.956276,"median":-9.285668,"eighty":-4.602511,"marketCap":207521747},{"date":"2020-07-10","current":2.432304,"twenty":-16.956276,"median":-9.285668,"eighty":-4.492878,"marketCap":207521747},{"date":"2020-07-17","current":2.632906,"twenty":-16.956276,"median":-9.285668,"eighty":-4.359841,"marketCap":224636943},{"date":"2020-07-24","current":2.169013,"twenty":-16.956276,"median":-9.285668,"eighty":-4.294153,"marketCap":185058053},{"date":"2020-07-31","current":5.291737,"twenty":-16.956276,"median":-9.285668,"eighty":-4.207243,"marketCap":207785354},{"date":"2020-08-07","current":5.018967,"twenty":-16.956276,"median":-9.236471,"eighty":-4.129361,"marketCap":197074769},{"date":"2020-08-14","current":4.937136,"twenty":-16.956276,"median":-9.114207,"eighty":-4.046708,"marketCap":193861593},{"date":"2020-08-21","current":4.800751,"twenty":-16.956276,"median":-9.044664,"eighty":-3.975947,"marketCap":188506301},{"date":"2020-08-28","current":4.746197,"twenty":-16.956276,"median":-8.995575,"eighty":-3.912026,"marketCap":186364184},{"date":"2020-09-04","current":4.364319,"twenty":-16.956276,"median":-8.901487,"eighty":-3.816494,"marketCap":171369364},{"date":"2020-09-11","current":4.17338,"twenty":-16.956276,"median":-8.827855,"eighty":-3.738465,"marketCap":163871955},{"date":"2020-09-18","current":4.418873,"twenty":-16.956276,"median":-8.760495,"eighty":-3.195538,"marketCap":173511481},{"date":"2020-09-25","current":4.146103,"twenty":-16.956276,"median":-8.729676,"eighty":-1.818959,"marketCap":162800896},{"date":"2020-10-02","current":3.955164,"twenty":-16.956276,"median":-8.622276,"eighty":-1.724348,"marketCap":155303486},{"date":"2020-10-09","current":4.255211,"twenty":-16.956276,"median":-8.54977,"eighty":-1.633594,"marketCap":167085130},{"date":"2020-10-16","current":4.009718,"twenty":-16.956276,"median":-8.515349,"eighty":-1.585828,"marketCap":157445603},{"date":"2020-10-23","current":3.62784,"twenty":-16.956276,"median":-8.427974,"eighty":-1.573886,"marketCap":142450784},{"date":"2020-10-30","current":-1.251207,"twenty":-16.956276,"median":-8.314168,"eighty":-1.54045,"marketCap":130397036},{"date":"2020-11-06","current":-1.206118,"twenty":-16.956276,"median":-8.15876,"eighty":-1.248953,"marketCap":125698044},{"date":"2020-11-13","current":-1.431561,"twenty":-16.956276,"median":-8.123908,"eighty":-1.248953,"marketCap":149193006},{"date":"2020-11-20","current":-1.69082,"twenty":-16.956276,"median":-8.062285,"eighty":-1.248953,"marketCap":176212212},{"date":"2020-11-27","current":-1.826086,"twenty":-16.956276,"median":-8.026159,"eighty":-1.248953,"marketCap":190309188},{"date":"2020-12-04","current":-1.780997,"twenty":-16.956276,"median":-7.930214,"eighty":-1.248953,"marketCap":185610196},{"date":"2020-12-11","current":-3.604211,"twenty":-16.956276,"median":-7.846235,"eighty":-1.248953,"marketCap":375620047},{"date":"2020-12-18","current":-4.570094,"twenty":-16.956276,"median":-7.770867,"eighty":-1.248953,"marketCap":476281486},{"date":"2020-12-24","current":-4.711855,"twenty":-16.956276,"median":-7.742788,"eighty":-1.248953,"marketCap":491055358},{"date":"2020-12-31","current":-4.617348,"twenty":-16.956276,"median":-7.650873,"eighty":-1.248953,"marketCap":481206110},{"date":"2021-01-08","current":-5.18439,"twenty":-16.956276,"median":-7.586524,"eighty":-1.248953,"marketCap":540301597},{"date":"2021-01-15","current":-9.275198,"twenty":-16.956276,"median":-7.541059,"eighty":-1.248953,"marketCap":966633326},{"date":"2021-01-22","current":-11.489365,"twenty":-16.956276,"median":-7.541059,"eighty":-1.248953,"marketCap":1197387133},{"date":"2021-01-29","current":-10.679304,"twenty":-16.956276,"median":-7.541059,"eighty":-1.248953,"marketCap":1112965009},{"date":"2021-02-05","current":-11.469113,"twenty":-16.956276,"median":-7.541059,"eighty":-1.248953,"marketCap":1195276580},{"date":"2021-02-12","current":-10.935823,"twenty":-16.956276,"median":-7.590597,"eighty":-1.248953,"marketCap":1139698682},{"date":"2021-02-19","current":-10.422785,"twenty":-16.956276,"median":-7.590597,"eighty":-1.248953,"marketCap":1086231336},{"date":"2021-02-26","current":-9.707231,"twenty":-16.956276,"median":-7.590597,"eighty":-1.248953,"marketCap":1011658459},{"date":"2021-03-05","current":-9.153689,"twenty":-16.967301,"median":-7.589308,"eighty":-1.246698,"marketCap":953970007},{"date":"2021-03-12","current":-16.837935,"twenty":-17.010109,"median":-7.589308,"eighty":-1.246698,"marketCap":986265176},{"date":"2021-03-19","current":-16.396766,"twenty":-17.010109,"median":-7.589308,"eighty":-1.246698,"marketCap":960424167},{"date":"2021-03-26","current":-14.411507,"twenty":-17.005242,"median":-7.590597,"eighty":-1.248953,"marketCap":844139626},{"date":"2021-04-01","current":-14.386998,"twenty":-17.005242,"median":-7.590597,"eighty":-1.248953,"marketCap":842704015},{"date":"2021-04-09","current":-13.16153,"twenty":-17.010109,"median":-7.589308,"eighty":-1.246698,"marketCap":770923434},{"date":"2021-04-16","current":-12.37723,"twenty":-17.010109,"median":-7.589308,"eighty":-1.246698,"marketCap":724983863},{"date":"2021-04-23","current":-12.181155,"twenty":-17.010109,"median":-7.589308,"eighty":-1.246698,"marketCap":713498970},{"date":"2021-04-30","current":-11.911552,"twenty":-17.010109,"median":-7.589308,"eighty":-1.246698,"marketCap":697707242},{"date":"2021-05-07","current":-51.179949,"twenty":-17.034321,"median":-7.589308,"eighty":-1.246698,"marketCap":661296119},{"date":"2021-05-14","current":-48.386283,"twenty":-17.14469,"median":-7.589308,"eighty":-1.246698,"marketCap":625199169},{"date":"2021-05-21","current":-48.721523,"twenty":-17.229399,"median":-7.589308,"eighty":-1.246698,"marketCap":629530803},{"date":"2021-05-28","current":-49.056763,"twenty":-17.276564,"median":-7.589308,"eighty":-1.246698,"marketCap":633862437},{"date":"2021-06-04","current":-49.615496,"twenty":-17.336739,"median":-7.589308,"eighty":-1.246698,"marketCap":641081827},{"date":"2021-06-11","current":-54.420601,"twenty":-17.405786,"median":-7.589308,"eighty":-1.246698,"marketCap":703168581},{"date":"2021-06-18","current":-51.850429,"twenty":-17.55155,"median":-7.589308,"eighty":-1.246698,"marketCap":669959387},{"date":"2021-06-25","current":-63.919063,"twenty":-17.703764,"median":-7.589308,"eighty":-1.246698,"marketCap":825898210},{"date":"2021-07-02","current":-46.039605,"twenty":-17.882624,"median":-7.589308,"eighty":-1.246698,"marketCap":594877731},{"date":"2021-07-09","current":-45.592618,"twenty":-18.089635,"median":-7.589308,"eighty":-1.246698,"marketCap":589102219},{"date":"2021-07-16","current":-41.457993,"twenty":-18.169925,"median":-7.589308,"eighty":-1.246698,"marketCap":535678734},{"date":"2021-07-23","current":-37.993848,"twenty":-18.418176,"median":-7.589308,"eighty":-1.246698,"marketCap":490918516},{"date":"2021-07-30","current":13.421548,"twenty":-18.586762,"median":-7.58374,"eighty":-1.239935,"marketCap":511132808},{"date":"2021-08-06","current":13.505476,"twenty":-18.586762,"median":-7.494267,"eighty":-0.139012,"marketCap":514329049},{"date":"2021-08-13","current":13.771033,"twenty":-18.586762,"median":-7.410756,"eighty":1.4692,"marketCap":524442260},{"date":"2021-08-20","current":13.164046,"twenty":-18.586762,"median":-7.374678,"eighty":1.522211,"marketCap":501326348},{"date":"2021-08-27","current":17.488833,"twenty":-18.586762,"median":-7.357508,"eighty":1.541853,"marketCap":666027223},{"date":"2021-09-03","current":18.854555,"twenty":-18.586762,"median":-7.32571,"eighty":1.591957,"marketCap":718038026},{"date":"2021-09-10","current":17.678517,"twenty":-18.55338,"median":-7.280241,"eighty":1.64006,"marketCap":673250946},{"date":"2021-09-17","current":18.437251,"twenty":-18.291425,"median":-7.254486,"eighty":1.672796,"marketCap":702145836},{"date":"2021-09-24","current":18.740745,"twenty":-18.144759,"median":-7.194389,"eighty":1.758622,"marketCap":713703792},{"date":"2021-10-01","current":18.285504,"twenty":-18.05656,"median":-7.157689,"eighty":1.833567,"marketCap":696366858},{"date":"2021-10-08","current":21.130759,"twenty":-17.723031,"median":-7.132486,"eighty":1.854022,"marketCap":804722697},{"date":"2021-10-15","current":23.369026,"twenty":-17.677304,"median":-7.108537,"eighty":1.934137,"marketCap":889962624},{"date":"2021-10-22","current":19.347733,"twenty":-17.677304,"median":-7.07701,"eighty":2.004131,"marketCap":736819705},{"date":"2021-10-29","current":20.068531,"twenty":-17.677304,"median":-7.040075,"eighty":2.082952,"marketCap":764269851},{"date":"2021-11-05","current":-10.337606,"twenty":-17.677304,"median":-7.005515,"eighty":2.103627,"marketCap":699256347},{"date":"2021-11-12","current":-11.226281,"twenty":-17.539079,"median":-7.005515,"eighty":2.103627,"marketCap":759368105},{"date":"2021-11-19","current":-10.918109,"twenty":-17.336739,"median":-7.005515,"eighty":2.103627,"marketCap":738522706},{"date":"2021-11-26","current":-10.433838,"twenty":-17.268845,"median":-7.005515,"eighty":2.103627,"marketCap":705765651},{"date":"2021-12-03","current":-9.179136,"twenty":-17.248444,"median":-7.005515,"eighty":2.103627,"marketCap":620895098},{"date":"2021-12-10","current":-9.047062,"twenty":-17.105388,"median":-7.005515,"eighty":2.103627,"marketCap":611961355},{"date":"2021-12-17","current":-8.518766,"twenty":-16.913249,"median":-7.005515,"eighty":2.103627,"marketCap":576226386},{"date":"2021-12-23","current":-9.59737,"twenty":-16.845582,"median":-7.005515,"eighty":2.103627,"marketCap":649185282},{"date":"2021-12-31","current":-8.672852,"twenty":-16.845582,"median":-7.005515,"eighty":2.103627,"marketCap":586649085},{"date":"2022-01-07","current":-7.770347,"twenty":-16.841758,"median":-7.0141,"eighty":2.101689,"marketCap":525601845},{"date":"2022-01-14","current":-7.594249,"twenty":-16.841758,"median":-7.0141,"eighty":2.101689,"marketCap":513690189},{"date":"2022-01-21","current":-6.933879,"twenty":-16.841758,"median":-7.002605,"eighty":2.101689,"marketCap":469021477},{"date":"2022-01-28","current":-6.647719,"twenty":-16.841758,"median":-6.978832,"eighty":2.101689,"marketCap":449665035},{"date":"2022-02-04","current":-6.691744,"twenty":-16.841758,"median":-6.950055,"eighty":2.101689,"marketCap":452642949},{"date":"2022-02-11","current":-6.603695,"twenty":-16.841758,"median":-6.93237,"eighty":2.101689,"marketCap":446687121},{"date":"2022-02-18","current":-6.031375,"twenty":-16.716955,"median":-6.908826,"eighty":2.101689,"marketCap":407974237},{"date":"2022-02-25","current":-6.27351,"twenty":-16.621345,"median":-6.869964,"eighty":2.101689,"marketCap":424352764},{"date":"2022-03-04","current":-3.613891,"twenty":-16.476249,"median":-6.823599,"eighty":2.101689,"marketCap":317147855},{"date":"2022-03-11","current":-3.562644,"twenty":-16.30945,"median":-6.799126,"eighty":2.101689,"marketCap":312650521},{"date":"2022-03-18","current":-3.733106,"twenty":-15.934558,"median":-6.740725,"eighty":2.101689,"marketCap":327609876},{"date":"2022-03-25","current":-3.562644,"twenty":-15.910237,"median":-6.708104,"eighty":2.101689,"marketCap":312650521},{"date":"2022-04-01","current":-3.835382,"twenty":-15.693561,"median":-6.691744,"eighty":2.101689,"marketCap":336585489},{"date":"2022-04-08","current":-4.346767,"twenty":-15.252179,"median":-6.648656,"eighty":2.101689,"marketCap":381463555},{"date":"2022-04-14","current":-3.971752,"twenty":-14.386998,"median":-6.612593,"eighty":2.101689,"marketCap":348552973},{"date":"2022-04-22","current":-3.409229,"twenty":-13.857596,"median":-6.554449,"eighty":2.101689,"marketCap":299187102},{"date":"2022-04-29","current":-3.085352,"twenty":-12.921338,"median":-6.470213,"eighty":2.101689,"marketCap":270764327},{"date":"2022-05-06","current":-2.982724,"twenty":-12.499776,"median":-6.4229,"eighty":2.101689,"marketCap":269268391},{"date":"2022-05-13","current":-2.866729,"twenty":-12.329715,"median":-6.391623,"eighty":2.101689,"marketCap":258796843},{"date":"2022-05-20","current":-2.933012,"twenty":-11.872337,"median":-6.336967,"eighty":2.101689,"marketCap":264780585},{"date":"2022-05-27","current":-2.8833,"twenty":-11.516367,"median":-6.287624,"eighty":2.101689,"marketCap":260292778},{"date":"2022-06-03","current":-2.999295,"twenty":-11.438061,"median":-6.27351,"eighty":2.101689,"marketCap":270764327},{"date":"2022-06-10","current":-2.551886,"twenty":-11.282217,"median":-6.243837,"eighty":2.101689,"marketCap":230374068},{"date":"2022-06-17","current":-2.419321,"twenty":-11.161263,"median":-6.216463,"eighty":2.101689,"marketCap":218406584},{"date":"2022-06-24","current":-3.36385,"twenty":-11.036975,"median":-6.174767,"eighty":2.103627,"marketCap":303674908},{"date":"2022-07-01","current":-3.214714,"twenty":-10.877178,"median":-6.121009,"eighty":2.103627,"marketCap":290211488},{"date":"2022-07-08","current":-4.755788,"twenty":-10.797409,"median":-6.078723,"eighty":2.103627,"marketCap":429333491},{"date":"2022-07-15","current":-5.103772,"twenty":-10.656336,"median":-6.023548,"eighty":2.103627,"marketCap":460748137},{"date":"2022-07-22","current":-5.103772,"twenty":-10.614494,"median":-5.983577,"eighty":2.103627,"marketCap":460748137},{"date":"2022-07-29","current":-4.387882,"twenty":-10.511341,"median":-5.95634,"eighty":2.103627,"marketCap":396120419},{"date":"2022-08-05","current":-5.441546,"twenty":-10.470612,"median":-5.855528,"eighty":2.103627,"marketCap":526719857},{"date":"2022-08-12","current":-6.346601,"twenty":-10.440728,"median":-5.830324,"eighty":2.103627,"marketCap":614325556},{"date":"2022-08-19","current":-6.146392,"twenty":-10.390783,"median":-5.830324,"eighty":2.103627,"marketCap":594946201},{"date":"2022-08-26","current":-5.585809,"twenty":-10.332367,"median":-5.786018,"eighty":2.103627,"marketCap":540684007},{"date":"2022-09-02","current":-5.445664,"twenty":-10.258952,"median":-5.721111,"eighty":2.103627,"marketCap":527118458},{"date":"2022-09-09","current":-5.806038,"twenty":-10.099573,"median":-5.68757,"eighty":2.103627,"marketCap":562001297},{"date":"2022-09-16","current":-5.265476,"twenty":-10.068694,"median":-5.634711,"eighty":2.103627,"marketCap":509677039},{"date":"2022-09-23","current":-4.664852,"twenty":-10.036262,"median":-5.565789,"eighty":2.103627,"marketCap":451538973},{"date":"2022-09-30","current":-4.804997,"twenty":-9.839731,"median":-5.505726,"eighty":2.103627,"marketCap":465104522},{"date":"2022-10-07","current":-4.584768,"twenty":-9.606175,"median":-5.474572,"eighty":2.103627,"marketCap":443787231},{"date":"2022-10-14","current":-4.224393,"twenty":-9.512878,"median":-5.418615,"eighty":2.103627,"marketCap":408904392},{"date":"2022-10-21","current":-3.88404,"twenty":-9.317108,"median":-5.36558,"eighty":2.103627,"marketCap":375959488},{"date":"2022-10-28","current":-4.404581,"twenty":-9.228668,"median":-5.326262,"eighty":2.103627,"marketCap":426345812},{"date":"2022-11-04","current":-4.164331,"twenty":-9.134909,"median":-5.265396,"eighty":2.103627,"marketCap":403090586},{"date":"2022-11-11","current":-4.608236,"twenty":-9.085323,"median":-5.218915,"eighty":2.103627,"marketCap":447280010},{"date":"2022-11-18","current":-4.316576,"twenty":-9.037986,"median":-5.148389,"eighty":2.103627,"marketCap":418971149},{"date":"2022-11-25","current":-4.141579,"twenty":-9.004961,"median":-5.113127,"eighty":2.103627,"marketCap":401985832},{"date":"2022-12-02","current":-4.394352,"twenty":-8.95385,"median":-5.103772,"eighty":2.103627,"marketCap":426520179},{"date":"2022-12-09","current":-3.966583,"twenty":-8.858944,"median":-5.051416,"eighty":2.103627,"marketCap":385000515},{"date":"2022-12-16","current":-4.044359,"twenty":-8.775492,"median":-4.989706,"eighty":2.103627,"marketCap":392549545},{"date":"2022-12-23","current":-3.791587,"twenty":-8.732948,"median":-4.945143,"eighty":2.103627,"marketCap":368015198},{"date":"2022-12-30","current":-3.713811,"twenty":-8.707473,"median":-4.931436,"eighty":2.103627,"marketCap":360466169},{"date":"2023-01-06","current":-4.161023,"twenty":-8.707473,"median":-4.905101,"eighty":2.103627,"marketCap":403873090},{"date":"2023-01-13","current":-4.588792,"twenty":-8.707473,"median":-4.825018,"eighty":2.103627,"marketCap":445392753},{"date":"2023-01-20","current":-4.511016,"twenty":-8.707473,"median":-4.800471,"eighty":2.103627,"marketCap":437843723},{"date":"2023-01-27","current":-4.316576,"twenty":-8.698971,"median":-4.744935,"eighty":2.103627,"marketCap":418971149},{"date":"2023-02-03","current":-4.588792,"twenty":-8.616688,"median":-4.716881,"eighty":2.103627,"marketCap":445392753},{"date":"2023-02-10","current":-4.43324,"twenty":-8.616688,"median":-4.689971,"eighty":2.103627,"marketCap":430294694},{"date":"2023-02-17","current":-4.7249,"twenty":-8.616688,"median":-4.664852,"eighty":2.103627,"marketCap":458603555},{"date":"2023-02-24","current":-4.33602,"twenty":-8.616688,"median":-4.656364,"eighty":2.103627,"marketCap":420858406},{"date":"2023-03-03","current":-4.9614,"twenty":-8.616688,"median":-4.628975,"eighty":2.103627,"marketCap":505784991},{"date":"2023-03-10","current":-4.091304,"twenty":-8.616688,"median":-4.617348,"eighty":2.103627,"marketCap":417083892},{"date":"2023-03-17","current":-4.165355,"twenty":-8.616688,"median":-4.588792,"eighty":2.103627,"marketCap":424632921},{"date":"2023-03-24","current":-4.294944,"twenty":-8.616688,"median":-4.584768,"eighty":2.103627,"marketCap":437843723},{"date":"2023-03-31","current":-4.498583,"twenty":-8.611752,"median":-4.5438,"eighty":2.101689,"marketCap":458603555},{"date":"2023-04-06","current":-4.276431,"twenty":-8.611752,"median":-4.514056,"eighty":2.101689,"marketCap":435956466},{"date":"2023-04-14","current":-4.554121,"twenty":-8.616688,"median":-4.498583,"eighty":2.103627,"marketCap":464265327},{"date":"2023-04-21","current":-4.535608,"twenty":-8.616688,"median":-4.494558,"eighty":2.103627,"marketCap":462378070},{"date":"2023-04-28","current":-4.368994,"twenty":-8.616688,"median":-4.48007,"eighty":2.103627,"marketCap":445392753},{"date":"2023-05-05","current":-5.265079,"twenty":-8.616688,"median":-4.469355,"eighty":2.103627,"marketCap":581275288},{"date":"2023-05-12","current":-5.391425,"twenty":-8.616688,"median":-4.469355,"eighty":2.103627,"marketCap":595224111},{"date":"2023-05-19","current":-4.962171,"twenty":-8.616688,"median":-4.469355,"eighty":2.103627,"marketCap":547833656},{"date":"2023-05-26","current":-4.979342,"twenty":-8.616688,"median":-4.469355,"eighty":2.103627,"marketCap":549729275},{"date":"2023-06-02","current":-5.833237,"twenty":-8.584045,"median":-4.469355,"eighty":2.103627,"marketCap":644000990},{"date":"2023-06-09","current":-6.620525,"twenty":-8.521315,"median":-4.469355,"eighty":2.103627,"marketCap":730919164},{"date":"2023-06-16","current":-5.615429,"twenty":-8.409344,"median":-4.469355,"eighty":2.103627,"marketCap":619954538},{"date":"2023-06-23","current":-5.069181,"twenty":-7.928531,"median":-4.469095,"eighty":2.105566,"marketCap":559647677},{"date":"2023-06-30","current":-4.741432,"twenty":-7.736918,"median":-4.468836,"eighty":2.107504,"marketCap":523463559},{"date":"2023-07-07","current":-4.850681,"twenty":-7.582546,"median":-4.468836,"eighty":2.107504,"marketCap":535524932},{"date":"2023-07-14","current":-5.025481,"twenty":-7.456725,"median":-4.468836,"eighty":2.107504,"marketCap":554823128},{"date":"2023-07-21","current":-4.588482,"twenty":-7.329223,"median":-4.468836,"eighty":2.107504,"marketCap":506577638},{"date":"2023-07-28","current":-4.173334,"twenty":-7.21107,"median":-4.452684,"eighty":2.107504,"marketCap":460744423},{"date":"2023-08-04","current":-4.195184,"twenty":-7.1497,"median":-4.43324,"eighty":2.107504,"marketCap":463156698},{"date":"2023-08-11","current":-3.222718,"twenty":-7.062715,"median":-4.424532,"eighty":2.107504,"marketCap":421270475},{"date":"2023-08-18","current":-3.016614,"twenty":-6.997689,"median":-4.394352,"eighty":2.107504,"marketCap":394328758},{"date":"2023-08-25","current":-3.260191,"twenty":-6.943891,"median":-4.387507,"eighty":2.107504,"marketCap":426168969},{"date":"2023-09-01","current":-3.222718,"twenty":-6.90323,"median":-4.368994,"eighty":2.107504,"marketCap":421270475},{"date":"2023-09-08","current":-3.035351,"twenty":-6.863653,"median":-4.359389,"eighty":2.109442,"marketCap":396778005},{"date":"2023-09-15","current":-2.510722,"twenty":-6.823379,"median":-4.352973,"eighty":2.109442,"marketCap":328199091},{"date":"2023-09-22","current":-2.117251,"twenty":-6.796445,"median":-4.333454,"eighty":2.109442,"marketCap":276764905},{"date":"2023-09-29","current":-2.061041,"twenty":-6.734167,"median":-4.316576,"eighty":2.109442,"marketCap":269417164},{"date":"2023-10-06","current":-1.967357,"twenty":-6.70066,"median":-4.308967,"eighty":2.109442,"marketCap":257170929},{"date":"2023-10-13","current":-1.94862,"twenty":-6.649594,"median":-4.300132,"eighty":2.109442,"marketCap":254721682},{"date":"2023-10-20","current":-2.164093,"twenty":-6.628424,"median":-4.294944,"eighty":2.109442,"marketCap":282888022},{"date":"2023-10-23","current":-2.117251,"twenty":-6.620525,"median":-4.2897,"eighty":2.109442,"marketCap":276764905},{"date":"2023-11-03","current":-2.623143,"twenty":-6.564354,"median":-4.275739,"eighty":2.127532,"marketCap":342894573},{"date":"2023-11-10","current":-1.605865,"twenty":-6.471058,"median":-4.251164,"eighty":2.127532,"marketCap":253497059},{"date":"2023-11-17","current":-1.644654,"twenty":-6.42548,"median":-4.238884,"eighty":2.127532,"marketCap":259620176},{"date":"2023-11-24","current":-1.753263,"twenty":-6.39868,"median":-4.221874,"eighty":2.127532,"marketCap":276764905},{"date":"2023-12-01","current":-1.644654,"twenty":-6.376178,"median":-4.204723,"eighty":2.127532,"marketCap":259620176},{"date":"2023-12-08","current":-1.939451,"twenty":-6.345167,"median":-4.184352,"eighty":2.123009,"marketCap":306155868},{"date":"2023-12-15","current":-2.017029,"twenty":-6.345167,"median":-4.183867,"eighty":2.123009,"marketCap":318402103},{"date":"2023-12-22","current":-1.970482,"twenty":-6.345167,"median":-4.166918,"eighty":2.123009,"marketCap":311054362},{"date":"2023-12-27","current":-2.1877,"twenty":-6.345884,"median":-4.164843,"eighty":2.127532,"marketCap":345343819},{"date":"2024-01-05","current":-2.473375,"twenty":-6.361389,"median":-4.159259,"eighty":2.134638,"marketCap":390439512},{"date":"2024-01-12","current":-2.179661,"twenty":-6.361389,"median":-4.131749,"eighty":2.134638,"marketCap":344074819},{"date":"2024-01-19","current":-2.009617,"twenty":-6.328248,"median":-4.113964,"eighty":2.135931,"marketCap":317232103},{"date":"2024-01-26","current":-2.751629,"twenty":-6.322599,"median":-4.102691,"eighty":2.134638,"marketCap":434363957},{"date":"2024-02-02","current":-3.060801,"twenty":-6.322599,"median":-4.102691,"eighty":2.134638,"marketCap":483168896},{"date":"2024-02-09","current":-3.555476,"twenty":-6.322599,"median":-4.06847,"eighty":2.134638,"marketCap":561256798},{"date":"2024-02-16","current":-5.534176,"twenty":-6.322599,"median":-4.0601,"eighty":2.134638,"marketCap":873608408},{"date":"2024-02-23","current":-3.663686,"twenty":-6.322599,"median":-4.044359,"eighty":2.134638,"marketCap":578338527},{"date":"2024-03-01","current":-3.849189,"twenty":-6.316949,"median":-4.029803,"eighty":2.133346,"marketCap":607621490},{"date":"2024-03-08","current":-3.323597,"twenty":-6.316949,"median":-3.99321,"eighty":2.133346,"marketCap":524653094},{"date":"2024-03-15","current":-3.407355,"twenty":-6.279585,"median":-3.959605,"eighty":2.133346,"marketCap":598355309},{"date":"2024-03-22","current":-3.37931,"twenty":-6.241527,"median":-3.932677,"eighty":2.133346,"marketCap":593430574},{"date":"2024-03-28","current":-3.044611,"twenty":-6.241527,"median":-3.904427,"eighty":2.133346,"marketCap":539258489},{"date":"2024-04-05","current":-2.863881,"twenty":-6.245755,"median":-3.869363,"eighty":2.134638,"marketCap":507247711},{"date":"2024-04-12","current":-2.822174,"twenty":-6.245755,"median":-3.821271,"eighty":2.134638,"marketCap":499860608},{"date":"2024-04-19","current":-2.26608,"twenty":-6.245755,"median":-3.791587,"eighty":2.134638,"marketCap":401365907},{"date":"2024-04-26","current":-2.140959,"twenty":-6.241527,"median":-3.77872,"eighty":2.133346,"marketCap":379204599},{"date":"2024-05-03","current":-2.162404,"twenty":-6.208395,"median":-3.737802,"eighty":2.133346,"marketCap":418602480},{"date":"2024-05-10","current":-2.404084,"twenty":-6.147658,"median":-3.705424,"eighty":2.133346,"marketCap":465387463},{"date":"2024-05-17","current":-3.43599,"twenty":-6.086923,"median":-3.664921,"eighty":2.133346,"marketCap":665145822},{"date":"2024-05-24","current":-3.006491,"twenty":-6.015292,"median":-3.630829,"eighty":2.133346,"marketCap":582002594},{"date":"2024-05-31","current":-3.174556,"twenty":-5.992734,"median":-3.613837,"eighty":2.133346,"marketCap":614536901},{"date":"2024-06-07","current":-3.267925,"twenty":-5.976881,"median":-3.589882,"eighty":2.133346,"marketCap":632611516},{"date":"2024-06-14","current":-3.417316,"twenty":-5.917432,"median":-3.562698,"eighty":2.134638,"marketCap":661530899},{"date":"2024-06-21","current":-3.267925,"twenty":-5.809662,"median":-3.559118,"eighty":2.135931,"marketCap":632611516},{"date":"2024-06-28","current":-3.249251,"twenty":-5.766461,"median":-3.548033,"eighty":2.143684,"marketCap":628996593},{"date":"2024-07-05","current":-3.099861,"twenty":-5.672546,"median":-3.529058,"eighty":2.143684,"marketCap":600077209},{"date":"2024-07-12","current":-3.473338,"twenty":-5.601059,"median":-3.499926,"eighty":2.143684,"marketCap":672375668},{"date":"2024-07-15","current":-3.697424,"twenty":-5.588141,"median":-3.499926,"eighty":2.143684,"marketCap":715754744},{"date":"2024-08-02","current":-3.613009,"twenty":-5.522921,"median":-3.493568,"eighty":2.170458,"marketCap":730214435},{"date":"2024-08-09","current":-3.004879,"twenty":-5.522921,"median":-3.493568,"eighty":2.170458,"marketCap":607307055},{"date":"2024-08-16","current":-2.933334,"twenty":-5.522921,"median":-3.493568,"eighty":2.170458,"marketCap":592847363},{"date":"2024-08-23","current":-3.273172,"twenty":-5.522921,"median":-3.493568,"eighty":2.170458,"marketCap":661530899},{"date":"2024-08-30","current":-3.219513,"twenty":-5.522921,"median":-3.493568,"eighty":2.170458,"marketCap":650686131},{"date":"2024-09-06","current":-2.897562,"twenty":-5.522921,"median":-3.493568,"eighty":2.170458,"marketCap":585617517},{"date":"2024-09-13","current":-2.986993,"twenty":-5.522921,"median":-3.493568,"eighty":2.170458,"marketCap":603692132},{"date":"2024-09-20","current":-3.022765,"twenty":-5.522921,"median":-3.477824,"eighty":2.170458,"marketCap":610921978},{"date":"2024-09-27","current":-2.754472,"twenty":-5.522921,"median":-3.442902,"eighty":2.170458,"marketCap":556698134},{"date":"2024-10-04","current":-2.879676,"twenty":-5.522921,"median":-3.416832,"eighty":2.170458,"marketCap":582002594},{"date":"2024-10-11","current":-3.022765,"twenty":-5.522921,"median":-3.408292,"eighty":2.170458,"marketCap":610921978},{"date":"2024-10-18","current":-3.595123,"twenty":-5.522921,"median":-3.38839,"eighty":2.170458,"marketCap":726599512},{"date":"2024-10-25","current":-3.291058,"twenty":-5.522921,"median":-3.37158,"eighty":2.170458,"marketCap":665145822},{"date":"2024-10-31","current":-3.487806,"twenty":-5.522921,"median":-3.341832,"eighty":2.170458,"marketCap":704909975},{"date":"2024-11-08","current":-2.325204,"twenty":-5.525747,"median":-3.323998,"eighty":2.169013,"marketCap":469939983},{"date":"2024-11-15","current":-1.770768,"twenty":-5.525747,"median":-3.323998,"eighty":2.099751,"marketCap":383181832},{"date":"2024-11-22","current":-1.289153,"twenty":-5.525747,"median":-3.323998,"eighty":2.035143,"marketCap":278963604},{"date":"2024-11-29","current":-1.34261,"twenty":-5.525747,"median":-3.323998,"eighty":1.983457,"marketCap":290531357},{"date":"2024-12-06","current":-1.085848,"twenty":-5.525747,"median":-3.323998,"eighty":1.886545,"marketCap":234969991},{"date":"2024-12-13","current":-1.373515,"twenty":-5.525747,"median":-3.323998,"eighty":1.84455,"marketCap":297218964},{"date":"2024-12-20","current":-1.2088,"twenty":-5.525747,"median":-3.323998,"eighty":1.792864,"marketCap":261575824},{"date":"2024-12-27","current":-1.311037,"twenty":-5.525747,"median":-3.323998,"eighty":1.699183,"marketCap":283699153},{"date":"2025-01-03","current":-1.298174,"twenty":-5.525747,"median":-3.323998,"eighty":1.669522,"marketCap":280915662},{"date":"2025-01-10","current":-1.435826,"twenty":-5.525747,"median":-3.325414,"eighty":1.638424,"marketCap":310702627},{"date":"2025-01-17","current":-1.19176,"twenty":-5.525747,"median":-3.325414,"eighty":1.581469,"marketCap":257888603},{"date":"2025-01-24","current":-1.478758,"twenty":-5.525747,"median":-3.325414,"eighty":1.540216,"marketCap":319992979},{"date":"2025-01-31","current":-1.368837,"twenty":-5.525747,"median":-3.325414,"eighty":1.522211,"marketCap":296206786},{"date":"2025-02-07","current":-1.236197,"twenty":-5.525747,"median":-3.325414,"eighty":1.467898,"marketCap":267504298},{"date":"2025-02-14","current":-1.238368,"twenty":-5.525747,"median":-3.325414,"eighty":-0.583112,"marketCap":267974238},{"date":"2025-02-21","current":-1.212809,"twenty":-5.525747,"median":-3.325414,"eighty":-1.155209,"marketCap":262443406},{"date":"2025-02-28","current":-1.119259,"twenty":-5.525747,"median":-3.325414,"eighty":-1.170645,"marketCap":242199837},{"date":"2025-03-07","current":-0.663267,"twenty":-5.525747,"median":-3.32683,"eighty":-1.175957,"marketCap":132920716},{"date":"2025-03-14","current":-0.643966,"twenty":-5.525747,"median":-3.32683,"eighty":-1.175957,"marketCap":129052749},{"date":"2025-03-21","current":-0.62214,"twenty":-5.525747,"median":-3.32683,"eighty":-1.175957,"marketCap":124678692},{"date":"2025-03-28","current":-0.62701,"twenty":-5.525747,"median":-3.32683,"eighty":-1.175957,"marketCap":125654721},{"date":"2025-04-04","current":-0.799456,"twenty":-5.525747,"median":-3.32683,"eighty":-1.175957,"marketCap":160213385},{"date":"2025-04-11","current":-0.893435,"twenty":-5.525747,"median":-3.325414,"eighty":-1.172148,"marketCap":179047133},{"date":"2025-04-17","current":-0.901913,"twenty":-5.525747,"median":-3.325414,"eighty":-1.172148,"marketCap":180746147}],"updateTime":1745098026994}}}